Pharma co Novartis plans review of Indian unit
Friday, 16 February 2024
Pharma giant Novartis AG is conducting a strategic review of Novartis India, including its shareholding in the BSE listed company. The review's outcome and timeline are uncertain. Novartis remains committed to India with over 8,100 associates and a diverse portfolio.
|
||||
You Might Like |
||||
